Overview

Early Intervention in Allergic Patients

Status:
Completed

Trial end date:
2020-11-10

Target enrollment:

Participant gender:

Summary

As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This study aimed to investigate the effects of early interventional treatment with the leukotriene receptor antagonist (LTRA) montelukast on seasonal allergic rhinitis.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Tongren Hospital

Treatments:

Montelukast